PyrAmes recognized in American Heart Association’s Health Tech Competition

The American Heart Association Center for Health Technology & Innovation selected PyrAmes as the best business pitch by a panel of expert judges at its annual Health Tech Competition during Scientific Sessions 2023. PyrAmes was one of five finalists in AHA’s competition, which aims to drive innovation and foster advancements with the potential to transform […]

Read More…

PyrAmes Receives FDA Clearance for its Groundbreaking Boppli® Wearable Blood Pressure Monitoring Device

boppli-hero

Boppli provides essential clinical information for newborns undergoing critical care Cupertino, CA, September 29, 2023 — PyrAmes Inc., a digital health company pioneering innovative blood pressure (BP) monitoring solutions, today announced it has received FDA 510(k) clearance for its revolutionary Boppli® platform to continuously and non-invasively monitor the blood pressure of critically-ill infants. Boppli offers […]

Read More…

West Coast Pediatrics Consortium recognizes PyrAmes for pediatric medical device innovation

PyrAmes has been awarded a Catalyzing Pediatric Innovation (CPI) grant by the West Coast Consortium for Technology & Innovation in Pediatrics (CTIP), centered at Children’s Hospital Los Angeles. Including PyrAmes, only five innovators were selected for developing novel devices and technologies for pediatric patients in CTIP’s seventh annual competition. PyrAmes was selected for its novel […]

Read More…

PyrAmes Inc. Announces Investment from March of Dimes to Support Maternal and Pediatric Health Products

CUPERTINO, CA and ARLINGTON, VA — PyrAmes Inc. has received an investment from March of Dimes, the leading organization fighting for the health of moms and babies, to support development and commercialization of its wearable technology to noninvasively monitor blood pressure, particularly for new mothers and their babies. PyrAmes’ goal is to develop more convenient, […]

Read More…

International Journal Sensors Highlights PyrAmes’ Technology in Neonatal Clinical Study

PyrAmes’ innovative Boppli™ blood pressure device is featured in the journal Sensors, in a paper reporting a clincal study of 81 infants undergoing critical care at Lucile Packard Children’s Hospital Stanford. Sensors is a leading international, peer-reviewed journal on the science and technology of sensors. The paper, Clinical Study of Continuous Non-Invasive Blood Pressure Monitoring […]

Read More…

PyrAmes recognized by Bear Institute for pediatric digital health innovation

PyrAmes has been awarded first place in the Early Commercialization Innovation Track in Bear Institute’s second annual Pediatric Accelerator Challenge for Kids (PACK). The Bear Institute for Health Innovation is a partnership between Children’s National Hospital and Oracle Health Cerner Corporation using HIT to improve the quality of care for children. The PACK awards recognize […]

Read More…

PyrAmes awarded prestigious AAP SOATT pediatric device award

SW National Pediatric Device Innovation Consortium recognizes Boppli™ platform for pediatric medical device innovation CUPERTINO, CA and HOUSTON, TX, October 21, 2022 – The Southwest National Pediatric Device Innovation Consortium (SWPDC) awarded PyrAmes $25,000 for its Boppli platform— a non-invasive wearable sensor intended for neonatal ICU patients for continuous blood pressure monitoring with minimal skin […]

Read More…

Sentec and PyrAmes form partnership to bring noninvasive care to critically ill infants

PyrAmes’ novel Boppli™ device enables continuous, noninvasive blood pressure monitoring (cNIBP) for the hospital’s most fragile patients. PROVIDENCE, RI and CUPERTINO, CA, September 13, 2022 — Sentec and PyrAmes have established a commercial partnership to bring Boppli, PyrAmes’ first-of-its-kind continuous noninvasive blood pressure device, to neonatal intensive care teams throughout the United States. Boppli has […]

Read More…

PyrAmes selected for LG NOVA’s Mission for the Future global challenge “First 50”

Congrats to the 50_FB

PyrAmes chosen from 1,300+ applicants to collaborate with LG on innovative connected health products. CUPERTINO, CA, February 10, 2022 — PyrAmes, Inc., a digital healthcare company focused on innovative products for continuous blood pressure monitoring, today announced its selection by the LG Electronics North American Innovation Center, LG NOVA in its inaugural cohort of startups […]

Read More…

PyrAmes selected for Plug and Play Japan’s Winter/Spring 2022 Batch Accelerator Program

Plug and Play Japan and its 49 corporate partners have selected PyrAmes for its global accelerator program, including 67 companies from Japan, the U.S., Canada, India, the United Kingdom, Spain, and more. PyrAmes receives business development resources in the program’s Health track, focusing on Plug and Play’s interest in sensors and wearables. Plug and Play Japan […]

Read More…

International Journal Sensors Showcases PyrAmes Technology and Applications

PyrAmes’ breakthrough blood pressure sensor is featured in Sensors, the leading international, peer-reviewed journal on the science and technology of sensors. The paper, Advances in Non-Invasive Blood Pressure Monitoring, highlights the added value of PyrAmes’ novel algorithm-based blood pressure sensor which uses machine-learning techniques to extract blood pressure values from the shape of the pulse […]

Read More…

SWPDC Pediatric Device Award

PyrAmes is honored to be selected by the Southwest National Pediatric Device Innovation Consortium (SWPDC) as a winner of the SWPDC Spring Competition. The SouthWest National Pediatric Device Innovation Consortium (SWPDC) is a “free no-strings-attached” virtual accelerator based at Texas Children’s Hospital and Baylor College of Medicine that supports pediatric device innovators nationwide throughout the […]

Read More…

One to Watch Award Exponential Medicine

Xina Quan, Co-founder and CEO of PyrAmes, accepted the One to Watch Award from Exponential Medicine. You can watch her acceptance presentation to the attendees starting at the 11:35 mark below. Exponential Medicine is an annual conference run by Singularity University, that provides leading scientists, inventors and thought leaders a forum to present and discuss […]

Read More…

Winner of Texas HALO FUND Corona Award (Ignite Fire Pitch Competition)

At Ignite Healthcare Networks’ third annual Pitch Competition, PyrAmes was awarded a Texas HALO FUND Corona Award.  The 10-week mini-accelerator program featured eight women-led digital health startup companies from Texas, California and Australia, and provided support to the businesses through $220,000 in cash prizes and investments, as well as mentorship from industry experts, investors and […]

Read More…

Selected for MedTech Innovator Accelerator

awards-MedtechInnovator

PyrAmes was selected by MedTech Innovator to participate in the 50 Best-in-Class Startups for 2019 Showcase and Accelerator from over 800 applicants.  The companies are part of an elite group of MedTech developers and will be featured at the Wilson Sonsini Goodrich & Rosati’s 27th Annual Medical Device Conference in San Francisco on June 21 […]

Read More…